- Student Records
Programme & Unit Catalogues


PA50337: Managing long term conditions 2

Follow this link for further information on academic years Academic Year: 2017/8
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%, OT 0%
Further information on unit assessment Assessment Detail:
  • Medicines Optimisation Tool (CW 60%)
  • CARE Tool (CW 20%)
  • Online Portfolio Task (CW 20%)
  • Workshop Attendance (OT 0%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites: In taking this module you cannot take PA50186
Further information on descriptions Description: Aims:
To update underpinning knowledge of key long term conditions and therapeutics enabling pharmacists to support patients in the self-management of their conditions through optimising medicines use.

Learning Outcomes:
On successful completion of this unit students will be able to:
1. Critically evaluate the evidence base for the management of key long term conditions (LTCs), specifically ischaemic heart disease (IHD), acute coronary syndrome (ACS), myocardial infarction (STEMI and NSTEMI), secondary prevention of IHD, chronic heart failure, lipid modification in primary and secondary cardiovascular disease (CVD risk reduction), peripheral arterial disease (PAD) and depression associated with LTCs. (Intellectual skill) (Medicines Optimisation Tool [MOT], portfolio task)
2. Reflect on your role in reviewing medication and monitoring their safety and effectiveness in patients with the above conditions. (knowledge and understanding) (MOT, Clinical Activity Reflective Exercise [CARE], portfolio task)
3. Explain the pathophysiology, symptoms and patient monitoring factors in the above conditions. (MOT, portfolio task)
4. Apply good communication and patient centred consultation skills to enhance the patient experience. ( Formative Work Based Assessment [WBA] and MOT)
5. Apply relevant clinical tools and interpret investigations to analyse risk and monitor patients with the above conditions. (taught / facilitated)
6. Safely review medication and optimise medicines use in patients with the above conditions. (MOT)

Skills:

* Planning & organisation
* Basic clinical examination skills
* Consultation skills
* Study skills
* Handling information
* communication skills
* Working with others
* Problem solving
* Scientific and practical skills
* Improving learning and performance
* Reflective practice
* Information & communication technology

Content:
Ischaemic Heart Disease (IHD) - Angina
Myocardial infarction - STEMI & NSTEMI
Secondary prevention of IHD
Chronic heart failure
Lipid modification in primary & secondary cardiovascular disease
Peripheral arterial disease
Depression associated with LTCs.
Further information on programme availabilityProgramme availability:

PA50337 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: